肥厚梗阻型心肌病的治疗进展  

PROGRESS IN THE TREATMENT OF HYPERTROPHIC OBSTRYCTIVE CARDIOMYOPATHY

作　　者：马国力 刘小平[1] 许心元 郝宇[1] 奇巴雅尔 王海军[1] MA Guoli;LIU Xiaoping;XU Xinyuan;HAO Yu;Qibayaer;WANG Haijun(Department of Iternal Medicine-Cardioascular.Ordos Cental Hospital,Ordos 07000,China)

机构地区：[1]鄂尔多斯市中心医院心血管内科,内蒙古鄂尔多斯017000

出　　处：《内蒙古医科大学学报》2024年第6期634-639,共6页Journal of Inner Mongolia Medical University

基　　金：鄂尔多斯市中心医院自主科研计划项目(EY2024QN10)。

摘　　要：肥厚梗阻型心肌病是一种常见的遗传性心脏疾病,具有较高的发病率和死亡率。尽管现在治疗和干预手段不断进步,但相较于其他心脏疾病,该病患者的治疗方案尚缺乏明确性。本综述聚焦于肥厚梗阻型心肌病的非侵入性和侵入性治疗的最新研究进展,特别强调了侵入性干预策略,如外科心肌切除术、二尖瓣修复或置换术、经皮酒精室间隔消融术、室间隔栓塞术、射频心内膜导管消融术、经皮心肌内室间隔射频消融术,以及起搏器和除颤器植入术等技术。Hypertrophic obstructive cardiomyopathy(HOCM)is a common inherited heart disease with a relatively high morbidity and mortality.Despite advancements in modern therapeutic and interventional methods,the treatment options for pa-tients with this disease lack clarity compared to other heart conditions.This review focuses on the latest research progress in both non-invasive and invasive treatments for HOCM,with a particular emphasis on invasive interventional strategies such as surgi-cal myectomy,mitral valve repair or replacement,percutaneous alcohol septal ablation,septal embolization,radiofrequency en-docardial catheter ablation,percutaneous intramyocardial septal radiofrequency ablation,and pacemaker and defibrillator im-plantation techniques.

关 键 词：肥厚梗阻型心肌病 

分 类 号：R542.2[医药卫生—心血管疾病]